Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Transplant Cell Ther. 2020 Oct 11;27(1):84.e1–84.e5. doi: 10.1016/j.bbmt.2020.10.008

Figure 2.

Figure 2.

Platelet engraftment in the foscarnet and no foscarnet groups. The cumulative incidence of platelet engraftment by 6 months was 92% (95% CI, 69% to 100%) in the foscarnet group versus 75% (95% CI, 60% to 90%) in the control group.